Author: Rafael Santos

AIBILI is proud to have developed for the SPO – Portuguese Society of Ophthalmology two registries for Keratoconus and Endophthalmitis. We congratulate SPO for the initiative which will contribute to foster ophthalmology clinical research. More information can be found here [https://spoftalmologia.pt/formularios/bases-de-dados/].

AIBILI Data Centre is a structure to support Investigator Initiated Research providing Data Management and Electronic Data Capture Solutions compliant with ECRIN Data Centre Certification requirements. Please check out our list of services here [https://www.aibili.pt/units-centres/dc/].

 

This week we have received the visit of Prof. António Costa e Silva, the Ministry of Economy and Maritime Affairs.
AIBILI Administration had the opportunity to showcase the skills and installed capacities and to reinforce the relevance that the institution plays in the national and international clinical research ecosystem.
Founded in 1989, AIBILI is a Centre for Technology and Innovation recognized by the Ministry of Economy, acting as a facilitating partnership between academic and scientific institutions, companies and industry and has the mission of responding to market failures and providing technical and technological support to companies in the health sector, specifically in clinical research.

AIBILI Annual Report 2023 is now available. Please check it here

AIBILI-Association for Innovation and Biomedical Research on Light and Image recently give an interview to Exame Informática program of SIC Notícias about the EVICR.net Eye Platform.

The EVICR.net Eye Platform is a long-term initiative to collect longitudinal anonymised clinical data and eye images from the network’s centers across Europe. The data platform is available for analysis by all EVICR.net partners to develop a better understanding of the progression of eye diseases and new ways to improve patient care and prevent vision loss.

Please check the extract of the program in this link
https://lnkd.in/dE6jKfCe

Boehringer Ingelheim is funding the EVICR.net Eye Platform and a pilot study that is collecting and will analyze data in patients with intermediate AMD or early atrophic AMD.

AIBILI is proud to perform a study on the effectiveness of educational materials available for Vabysmo®, Eylea® and Lucentis®.

The MARVEL Study, supported by INFARMED, I.P., is conducted by the Coimbra Regional Pharmacovigilance Unit of AIBILI and aims to evaluate the effectiveness of educational materials for healthcare professionals and the target general population, as additional measures of risk minimization for the drugs Vabysmo® (faricimab), Eylea® (aflibercept) and Lucentis® (ranibizumab).

More information: https://www.infarmed.pt/web/infarmed/infarmed/-/journal_content/56/15786/9521902

Presentations:

• Abnormal retinal fluid in eyes with diabetic center-involved macular edema

Prof. José Cunha-Vaz

 

• A Conversion Model for OCTA Vessel Density Metrics in Diabetic Eyes: Angiovue vs Cirrus Angioplex

Doutora Ana Rita Santos

 

• Statins and genetics in the risk of progression of age-related macular degeneration – The Coimbra Eye Study

Dra. Patrícia Barreto

 

• Combination of Ultra-widefield Colour Fundus Photography and Optical Coherence Tomography Angiography identify different subtypes of non-proliferative diabetic retinopathy

Dra. Ana Almeida

 

Posters:

• CLARUS (or Wide-Field Fundus Imaging) Improves ETDRS Grading with Classic 7-fields Fundus Photographs

Dra. Marta Lopes

 

Audio narrated free paper:

• Statin intake time and risk for progression of age-related macular degeneration – a comparison of two Cox regression models applied to the Coimbra Eye Study

Doutora Rita Coimbra

AIBILI will be presenting at EVOLVE – Digital Transformation Summit 2023 the EVICR.net Eye Platform. This summit will be organised by APDC on October 11, 2023, in Lisbon, Portugal. The EVICR.net Eye Platform is a long-term initiative to collect longitudinal anonymised clinical data and eye images from the network’s centers across Europe. The data platform will be available for analysis by all EVICR.net partners to develop a better understanding of the progression of eye diseases and new ways to improve patient care and prevent vision loss.
Boehringer Ingelheim is funding the EVICR.net Eye Platform and a pilot study that is collecting and will analyze data in patients with intermediate AMD or early atrophic AMD.
Learn more at: https://www.evicr.net/eyeplatform/

AIBILI was present at this ERA4Health workshop – Analysis of bottlenecks and challenges in designing and conducting investigator-initiated multinational clinical studies – through Dr. Cecília Martinho and Dr. Joana Tavares, which took place in Paris, France, on 15-16/09/2023. Challenges in designing and conducting investigator-initiated multinational clinical studies were discussed.

‘À Mesa com Saúde’ is a health literacy initiative organized by Faculty of Medicine of the Coimbra University and iCBR – Coimbra Institute for Clinical and Biomedical Research, in partnership with the Coimbra School of Tourism and the Coimbra University Hospital, which consists of organizing dinners commented by chefs, scientists and clinicians, which aim to address diseases and their prevention through diet. The dinner on May 5th has Vision Sciences as its theme and has the participation of Dr. Patricia Barreto from AIBILI.

AIBILI, as Coordinating Centre of EVICR.net, is organizing the EVICR.net 18th Members Meeting on October 19-20, 2023, in Milan, Italy.